glp 1 drug shortage FDA says that the GLP-1 is over A Major GLP-1 Drug Shortage
Description
News Brief Swarajya News Staff Apr 01, 2026 | Updated 02:46 PM GMT+5:30 Save & read from anywhere

Exenatide extended-release (ER) , taken weekly: FDA-approved under the brand name Bydureon to treat type 2 diabetes
These results however did not translate to significant in vitro increases in cAMP-responsive glucose-6-phosphatase upregulation or glucose production [95]

Roostalu, A

Resources We Trust Mayo Clinic: The Reality of Menopause Weight Gain UChicago Medicine: Why Am I Gaining Weight So Fast During Menopause

The physiological evidence for a direct action of GLP-1 on pancreatic acinar cells is unclear
